| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President, R&D | SVP, Research And Development
1 company
Glenn Gregory M is a President, R&D at NOVAVAX INC. Recent SEC Form 4 filings include 0 buys and 153 sells.
Estimated insider holdings value: $152K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 16, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 1,866 | $233.52 | $435,750.33 | -2.1% | -24.8% | -81.3% | |
| Jul 20, 2021 | NVAX Novavax Inc | President, R&D | Sell | 2,409 | $215.43 | $518,981.91 | -3.2% | -19.8% | -71.2% | |
| Jul 15, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 5,654 | $179.45 | $1,014,596.90 | -14.2% | -7.1% | -69.6% | |
| Jun 17, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 8,127 | $189.00 | $1,536,016.76 | -9.6% | +29.1% | -77.6% | |
| May 19, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 8,097 | $136.39 | $1,104,333.12 | -15.8% | +65.0% | -58.9% | |
| Apr 19, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 8,129 | $206.11 | $1,675,439.16 | -8.4% | -5.0% | -75.4% | |
| Mar 17, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 8,135 | $204.63 | $1,664,704.33 | -10.2% | -17.0% | -64.9% | |
| Feb 18, 2021 | NVAX Novavax Inc | President, R&D | Sell | 2,434 | $269.57 | $656,134.14 | -4.9% | - | - | |
| Feb 16, 2021 | NVAX Novavax Inc | President, R&D | Sale+OE | 5,712 | $282.71 | $1,614,811.95 | -5.3% | - | - | |
| Sep 29, 2020 | NVAX Novavax Inc | President, R&D | Sale+OE | 44,949 | $108.84 | $4,892,299.82 | -11.7% | - | - |